🔎 Trials Near Me

Home › Diffuse Intrinsic Pontine Glioma › Texas

Pag-aaral pangklinika para sa Diffuse Intrinsic Pontine Glioma sa Texas

11 pag-aaral para sa Diffuse Intrinsic Pontine Glioma ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Texas Children's Hospital, Houston
Nagre-recruitPhase 2
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06838676

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • Cook Children's Medical Center, Fort Worth
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Nagre-recruitPhase 1/2
12 Months – 21 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04870944

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

  • The University of Texas M. D. Anderson Cancer Center, Houston
Nagre-recruitPhase 1
36 Months · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07076498

Targeted Pediatric High-Grade Glioma Therapy

  • Texas Children's Hospital, Houston
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Children's Medical Center, Dallas
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199

Study of Olutasidenib and Temozolomide in HGG

  • Texas Children's Hospital, Houston
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Texas Children's Hospital, Houston
Nagre-recruitPhase 2
Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

  • Texas Children's Hospital, Houston
Nagre-recruitPhase 1
12 Months – 25 Years · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT04099797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Texas Children's Hospital, Houston
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Texas Children's Hospital, Houston
Nagre-recruitPhase 2
12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Texas Children's Hospital, Houston
Nagre-recruitMaagang Phase 1
Hanggang edad 21 · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT04655404

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.